Crossmark

Prospective pre- and post-race evaluation of biochemical, electrophysiologic, and echocardiographic indices in 30 racing thoroughbred horses that received furosemide

Crossref DOI link: https://doi.org/10.1186/s12917-018-1336-0

Published Online: 2018-01-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gunther-Harrington, Catherine T.

Arthur, Rick

Estell, Krista

Martinez Lopez, Beatriz

Sinnott, Alexandra

Ontiveros, Eric

Varga, Anita

Stern, Joshua A. http://orcid.org/0000-0001-5611-5745
Funding

Funding for this research was provided by:

Marcia MacDonald Rivas; UC Davis Center for Equine Health (14-04)
More Information

Article History

Received: 11 September 2017

Accepted: 4 January 2018

First Online: 18 January 2018

Ethics approval and consent to participate

: Written consent for participation was obtained from all horse owners. This study was performed in accordance with the institutional animal care and use committee at the University of California Davis (approved IACUC protocol# 18285).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below